Adalimumab for adult patients with rheumatological disorders : a review of clinical effectiveness /
The objective of this report is to summarize the evidence regarding the comparative efficacy of ADA compared with other bDMARDs and tofacitinib in patients with rheumatological disorders.
Saved in:
Online Access: |
Full text |
---|---|
Main Authors: | , , |
Format: | Electronic eBook |
Language: | English |
Published: |
Ottawa (ON) :
CADTH,
2020
|
Edition: | Version 2.0. |
Series: | Rapid response report (Canadian Agency for Drugs and Technologies in Health)
|
Subjects: |